Asphyxia Neonatorum Clinical Trial
— AAMBIOfficial title:
Verification of Biomarkers to Examine Neonatal Asphyxia Induced Hypoxic-ischemic Encephalopathy. A Prospective Multicenter Observational Study for Development of a Diagnostic Test
NCT number | NCT03354208 |
Other study ID # | AAMBI I |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 2016 |
Est. completion date | December 27, 2017 |
Verified date | January 2021 |
Source | Life Science Inkubator |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Verification of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies.
Status | Completed |
Enrollment | 155 |
Est. completion date | December 27, 2017 |
Est. primary completion date | December 27, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 2 Hours |
Eligibility | Inclusion Criteria: Group 1: inclusion criteria fulfilled for hypothermia treatment Group 2: Infants with suspected perinatal brain injury due to one of the followings - Perinatal hypoxia-ischemia (defined as a perinatal acidosis indicated by a pH=7.10 or a base excess =-12mmol/l in umbilical cord blood or early postnatal blood collected at <90min of age (outborn patients) - 5min APGAR-score = 5 - Need for resuscitation after birth for >1 min. after birth, positive pressure respiratory support with face mask or endotracheal tube, or cardiac compressions Group 3: UApH >7,25, and adaptation disorder of the newborn and need of postnatal clinical surveillance Exclusion Criteria: gestational age < 36 weeks - age at time of screening >2,5h - congenital malformation - missing or invalid informed parental consent - unsuccessful resuscitation - infant considered not-viable - decision for palliative care only |
Country | Name | City | State |
---|---|---|---|
Turkey | Cukurova University | Adana | |
Turkey | University of Firat | Elazig | |
Turkey | Özel Güngören Hastanesi | Istanbul | |
Turkey | Mersin University School of Medicine | Mersin |
Lead Sponsor | Collaborator |
---|---|
Life Science Inkubator | Cukurova University, University Children's Hospital Tuebingen |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | abnormal short-term outcome (NE) | All patients are classified as abnormal short-term outcome (neonatal encephalopathy, NE) or normal short term outcome (no encephalopathy) by using clinical data, particularly Thompson score. For Group 1 and group 2 patients outcome classification will be additionally confirmed by using cranial ultrasound or MRI (including severe ischemia based on DWI or thalamic or cerebellar bleeding or arterial infarction or IVH>2° according to Papile, thalamic ischemia or severe cerebral edema) or seizure activity or burst suppression on aEEG or persistingly abnormal aEEG background pattern after complete rewarming.
Bloodplasma samples will be analysed by a metabolomics approach using the p180-kit (Biocrates, Innsbruck, Austria). Metabolite concentrations or combinations thereof will be compared to the outcome described above in order to identify the most suitable metabolites to be used for early detection of NE in newborn infants. |
14 days for clinical diagnosis |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04070560 -
Effects of Delayed Cord Clamping During Resuscitation of Newborn Near Term and Term Infants
|
N/A | |
Completed |
NCT03357250 -
Biomarkers And Neurological Outcome in Neonates (BANON)
|
||
Completed |
NCT02572427 -
Resident Training Enhanced by New Innovations: Teleintubation
|
N/A | |
Completed |
NCT00097097 -
Neonatal Resuscitation in Zambia
|
Phase 3 | |
Active, not recruiting |
NCT03133572 -
Neonatal Resuscitation With Supraglottic Airway Trial
|
N/A | |
Completed |
NCT01866358 -
Intraosseous Infusion for Neonatal Asphyxiated Resuscitation
|
N/A | |
Completed |
NCT00136708 -
First Breath: Neonatal Resuscitation in Developing Countries
|
N/A | |
Completed |
NCT04820504 -
Augmented Infant Resuscitator to Enhance Newborn Ventilation
|
N/A | |
Not yet recruiting |
NCT04145713 -
Effects of Probiotic Mixture Supplementation and Evaluation of Intestinal Mucosal Tolerance and Gut Microbiome in Newborns With Perinatal Asphyxia Receiving Hypothermic Treatment
|
Phase 3 | |
Completed |
NCT03284528 -
Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"
|
N/A | |
Completed |
NCT03278847 -
Optimising Newborn Nutrition During Therapeutic Hypothermia.
|
||
Recruiting |
NCT04239508 -
Swiss Neonatal Network & Follow-up Group
|
||
Recruiting |
NCT04714775 -
Biomarkers And Neurological Outcome in Neonates 2
|
||
Active, not recruiting |
NCT05349175 -
Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement
|
N/A | |
Completed |
NCT03606278 -
Evaluation of Two Strategies for Debriefing in the Development of Skills for Neonatal Resuscitation
|
N/A | |
Completed |
NCT00147030 -
TOBY: a Study of Treatment for Perinatal Asphyxia
|
N/A | |
Withdrawn |
NCT03913533 -
Heart Rate Assessment at Birth Comparing Stethoscope Versus Tap-based Application
|
N/A | |
Recruiting |
NCT04867993 -
Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia
|
N/A | |
Active, not recruiting |
NCT03179553 -
Heart Beat Variability in Neonatal Encephalopathy
|
||
Completed |
NCT03177980 -
Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants
|